Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0291927 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Yu-Sung Chiu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, Fu-Jen Catholic University, New Taipei City, Taiwan. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Fu Jen Catholic University.
Abstract (Originalsprache)
Abnormal accumulation of alpha-synuclein (αSyn) in the remaining nigra dopaminergic neurons is a common neuropathological feature found in patients with Parkinson’s disease (PD). Antibody-based immunotherapy has been considered a potential approach for PD treatment. This study aims to investigate the effectiveness of active immunization against αSyn in a mouse model of PD. Adult mice were immunized with or without a synthetic peptide containing the C-terminal residues of human αSyn and activation epitopes, followed by an intranigral injection of adeno-associated virus vectors for overexpressing human αSyn. Upon the peptide injection, αSyn-specific antibodies were raised, accompanied by degeneration of dopaminergic neurons and motor deficits. Furthermore, the induction of neuroinflammation was postulated by the elevation of astroglial and microglial markers in the immunized mice. Instead of lessening αSyn toxicity, this peptide vaccine caused an increase in the pathogenic species of αSyn. Our data demonstrated the potential adverse effects of active immunization to raise antibodies against the C-terminal fragment of αSyn. This drawback highlights the need for further investigation to weigh the pros and cons of immunotherapy in PD. Applying the αSyn C-terminal peptide vaccine for PD treatment should be cautiously exercised. This study provides valuable insights into the intricate interplay among immune intervention, αSyn accumulation, and neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Life Science, Fu-Jen Catholic University, New Taipei City, Taiwan.
- National Health Research Institutes, Center for Neuropsychiatric Research, Zhunan, Taiwan.
- School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan.
- Department of Electrical Engineering of I-Shou University, Kaohsiung, Taiwan.
- Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
- Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung City, Taiwan.
ORCID-Profile: Yu-Sung Chiu, Hsi Chen, Yun-Hsiang Chen
Förderung
- Ministry of Science and Technology
- Fu Jen Catholic University
Zitieren
APA
Chiu, Y. S., Wu, K. J., Yu, S. J., Wu, K. L., Wang, Y. S., Lin, J., Chu, C. Y., Chen, S., Chen, H., Hsu, S. C., Wang, Y., & Chen, Y. H. (2023). Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein. PLOS ONE. https://doi.org/10.1371/journal.pone.0291927
Vancouver
Chiu YS, Wu KJ, Yu SJ, Wu KL, Wang YS, Lin J, et al. Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein. PLOS ONE. 2023. doi:10.1371/journal.pone.0291927
BibTeX
@article{Chiu2023,
author = {Chiu, Yu-Sung and Wu, Kuo-Jen and Yu, Seong-Jin and Wu, Kun-Lieh and Wang, Yu-Syuan and Lin, Jing and Chu, Chia-Ying and Chen, Shuchun and Chen, Hsi and Hsu, Shu-Ching and Wang, Yun and Chen, Yun-Hsiang},
title = {Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0291927}
}
EUVIMED